FDS:NYSEFactSet Research Systems Inc. Analysis
Data as of 2026-03-14 - not real-time
$205.65
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
FactSet (FDS) is trading at $205.65, well below its DCF‑derived fair value of $231, implying a potential upside of roughly 44%. Technical indicators show the stock is in a bearish price trend, with the 20‑day SMA (~$209) and 50‑day SMA (~$241) both above the current price. The 14‑day RSI sits at 39, suggesting the shares are approaching oversold territory. Conversely, the MACD histogram is positive, indicating a nascent bullish momentum despite the broader downtrend. Volume has been decreasing, which could limit short‑term price rebounds, while the beta of 0.59 points to lower systematic risk relative to the market. The company maintains a solid dividend yield of 2.14% with a modest payout ratio of 27%, supported by free cash flow of $545 million and a strong operating margin of 32%.
Fundamentally, FactSet delivers a PE of 13 versus an industry average of 16, and its revenue is growing at 6.8% YoY, underscoring a blend of value and growth characteristics. The balance sheet shows ample cash ($293 million) against debt of $1.56 billion, resulting in a debt‑to‑equity of 72%, which is manageable given the robust cash generation. Analyst consensus remains a 'hold' with a median price target near $305, reflecting confidence in the long‑run upside but caution on near‑term volatility. Recent news confirms continued investment in the platform, highlighted by the appointment of new executives to drive product innovation. Given the high 30‑day volatility of nearly 60% and a max drawdown of –60%, investors should be prepared for price swings. Overall, the combination of undervaluation, resilient cash flow, and a sustainable dividend makes FactSet an attractive candidate for medium‑ to long‑term accumulation.
Fundamentally, FactSet delivers a PE of 13 versus an industry average of 16, and its revenue is growing at 6.8% YoY, underscoring a blend of value and growth characteristics. The balance sheet shows ample cash ($293 million) against debt of $1.56 billion, resulting in a debt‑to‑equity of 72%, which is manageable given the robust cash generation. Analyst consensus remains a 'hold' with a median price target near $305, reflecting confidence in the long‑run upside but caution on near‑term volatility. Recent news confirms continued investment in the platform, highlighted by the appointment of new executives to drive product innovation. Given the high 30‑day volatility of nearly 60% and a max drawdown of –60%, investors should be prepared for price swings. Overall, the combination of undervaluation, resilient cash flow, and a sustainable dividend makes FactSet an attractive candidate for medium‑ to long‑term accumulation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating oversold conditions
- Positive MACD histogram suggesting emerging bullish momentum
- Proximity to support level at $185
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of approximately 44%
- Revenue growth and high operating margins
- Low beta reducing market risk
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Recurring subscription revenue model
- Sustainable dividend yield
- Long‑term undervaluation relative to peers
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin25.40%
P/E Ratio13.1
ROE28.83%
ROA11.42%
Debt/Equity71.96
P/B Ratio3.5
Op. Cash Flow$761.2M
Free Cash Flow$545.5M
Industry P/E16.4
Technical Analysis
TrendBearish
RSI39.3
Support$185.00
Resistance$230.03
MA 20$209.20
MA 50$241.35
MA 200$321.09
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$231.10
Target Price$296.71
Upside/Downside44.28%
GradeUndervalued
TypeBlend
Dividend Yield2.14%
Risk Assessment
Beta0.59
Volatility59.79%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.